VANECK ETF TR (BBH) - 5i Research

VANECK ETF TR (BBH $154.83)
- $154.83 P/E (TTM): 60.92X Cap: $333M
- View BBH Profile
- View Questions on BBH

{tplLang.businessdescription | toLang tLang}

{ profileData.description }

{tplLang.details | toLang tLang}

{tplLang.ceo | toLang tLang}

{profileData.profile.details.ceo}

{tplLang.employees | toLang tLang}

{profileData.profile.details.employees | numeraljs '0,0'}

{tplLang.issuetype | toLang tLang}

{profileData.profile.details.issuetype | asIssueType}

{tplLang.industryclassifications | toLang tLang}

{tplLang.sector | toLang tLang}

{profileData.profile.classification.sector}

{tplLang.industry | toLang tLang}

{profileData.profile.classification.industry}

{tplLang.toolname| toLang tLang}

There is no {tplLang.toolname| toLang tLang} currently available for {data.symbolstring}.

iShares Biotechnology ETF (IBB $129.12)
- $129.12 P/E (TTM): 41.5X Cap: $5.42B
- View IBB Profile
- View Questions on IBB
Moderna Inc. (MRNA $30.95)
- $30.95 Cap: $12.08B
- View MRNA Profile
- View Questions on MRNA
VANECK ETF TR (BBH $154.83)
- $154.83 P/E (TTM): 60.92X Cap: $333M
- View BBH Profile
- View Questions on BBH

Q: Currently not invested in this sector. Considering starting a position in this company. Appreciate your insights.
Thank you

Read Answer Asked by Larry on September 07, 2023

iShares Biotechnology ETF (IBB $129.12)
- $129.12 P/E (TTM): 41.5X Cap: $5.42B
- View IBB Profile
- View Questions on IBB
CRISPR Therapeutics AG (CRSP $65.72)
- $65.72 Cap: $5.62B
- View CRSP Profile
- View Questions on CRSP
VANECK ETF TR (BBH $154.83)
- $154.83 P/E (TTM): 60.92X Cap: $333M
- View BBH Profile
- View Questions on BBH

Q: I am down by 55% on this company, although it is a small position (.8%) & I consider it speculative. Your comments will help me decide to wait, sell, or buy more. Thanks

Read Answer Asked by Louisa on March 30, 2023

Regeneron Pharmaceuticals Inc. (REGN $545.63)
- $545.63 P/E (TTM): 13.79X Cap: $58.57B
- View REGN Profile
- View Questions on REGN
Johnson & Johnson (JNJ $164.24)
- $164.24 P/E (TTM): 18.21X Cap: $393.87B
- View JNJ Profile
- View Questions on JNJ
Eli Lilly and Company (LLY $762.62)
- $762.62 P/E (TTM): 62.79X Cap: $731.37B
- View LLY Profile
- View Questions on LLY
Merck & Company Inc. (MRK $79.29)
- $79.29 P/E (TTM): 11.65X Cap: $200.78B
- View MRK Profile
- View Questions on MRK
Pfizer Inc. (PFE $24.28)
- $24.28 P/E (TTM): 17.73X Cap: $139.12B
- View PFE Profile
- View Questions on PFE
Thermo Fisher Scientific Inc (TMO $406.39)
- $406.39 P/E (TTM): 24.33X Cap: $156.56B
- View TMO Profile
- View Questions on TMO
Novo Nordisk A/S (NVO $64.93)
- $64.93 P/E (TTM): 18.14X Cap: $363.68B
- View NVO Profile
- View Questions on NVO
iShares Biotechnology ETF (IBB $129.12)
- $129.12 P/E (TTM): 41.5X Cap: $5.42B
- View IBB Profile
- View Questions on IBB
Moderna Inc. (MRNA $30.95)
- $30.95 Cap: $12.08B
- View MRNA Profile
- View Questions on MRNA
VANECK ETF TR (BBH $154.83)
- $154.83 P/E (TTM): 60.92X Cap: $333M
- View BBH Profile
- View Questions on BBH
iShares U.S. Pharmaceuticals ETF (IHE $66.95)
- $66.95 P/E (TTM): 57.72X Cap: $557M
- View IHE Profile
- View Questions on IHE

Q: I'm looking for names in the large cap pharma and biotech sectors. Can you suggest two stocks for each sector that look attractive to you right now for a 5+ year horizon? Thanks.

Read Answer Asked by Stefan on March 10, 2023